These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 19878335)
1. Early long-term FEIBA prophylaxis in haemophilia A patients with inhibitor after failing immune tolerance induction: A prospective clinical case series. Ettingshausen CE; Kreuz W Haemophilia; 2010 Jan; 16(1):90-100. PubMed ID: 19878335 [TBL] [Abstract][Full Text] [Related]
2. Prophylaxis with FEIBA in paediatric patients with haemophilia A and inhibitors. Ewing N; Escuriola-Ettingshausen C; Kreuz W Haemophilia; 2015 May; 21(3):358-364. PubMed ID: 25603840 [TBL] [Abstract][Full Text] [Related]
3. Assessing the benefits of FEIBA prophylaxis in haemophilia patients with inhibitors. Valentino LA Haemophilia; 2010 Mar; 16(2):263-71. PubMed ID: 20028421 [TBL] [Abstract][Full Text] [Related]
4. Prophylactic treatment with activated prothrombin complex concentrate (FEIBA) reduces the frequency of bleeding episodes in paediatric patients with haemophilia A and inhibitors. Leissinger CA; Becton DL; Ewing NP; Valentino LA Haemophilia; 2007 May; 13(3):249-55. PubMed ID: 17498073 [TBL] [Abstract][Full Text] [Related]
5. Prophylaxis in 10 patients with severe haemophilia A and inhibitor: different approaches for different clinical situations. Jiménez-Yuste V; Alvarez MT; Martín-Salces M; Quintana M; Rodriguez-Merchan C; Lopez-Cabarcos C; Velasco F; Hernández-Navarro F Haemophilia; 2009 Jan; 15(1):203-9. PubMed ID: 19149850 [TBL] [Abstract][Full Text] [Related]
6. FEIBA prophylaxis in haemophilia patients: a clinical update and treatment recommendations. Perry D; Berntorp E; Tait C; Dolan G; Holme PA; Laffan M; Lassila R; Mumford A; Pasi J; Wilde J; Will A; Yee TT Haemophilia; 2010 Jan; 16(1):80-9. PubMed ID: 19780845 [TBL] [Abstract][Full Text] [Related]
7. Long-term FEIBA prophylaxis does not prevent progression of existing joint disease. Hilgartner MW; Makipernaa A; Dimichele DM Haemophilia; 2003 May; 9(3):261-8. PubMed ID: 12694515 [TBL] [Abstract][Full Text] [Related]
8. Complete immunotolerance induction after FEIBA prophylaxis in a haemophilia A patient with high-titre inhibitor. Nanishi E; Ohga S; Doi T; Ishimura M; Ihara K; Takada H; Shima M; Hara T Haemophilia; 2012 May; 18(3):e75-7. PubMed ID: 22404696 [No Abstract] [Full Text] [Related]
9. Prophylaxis in haemophilia patients with inhibitors. Leissinger CA Haemophilia; 2006 Dec; 12 Suppl 6():67-72; discussion 72-3. PubMed ID: 17123397 [TBL] [Abstract][Full Text] [Related]
10. The benefits of prophylactic treatment with APCC in patients with haemophilia and high-titre inhibitors: a retrospective case series. Valentino LA Haemophilia; 2009 May; 15(3):733-42. PubMed ID: 19298380 [TBL] [Abstract][Full Text] [Related]
11. Prophylaxis in haemophilia with inhibitors: update from international experience. Carcao M; Lambert T Haemophilia; 2010 Mar; 16 Suppl 2():16-23. PubMed ID: 20132334 [TBL] [Abstract][Full Text] [Related]
12. Experiences in the prevention of arthropathy in haemophila patients with inhibitors. Jimenez-Yuste V; Rodriguez-Merchan EC; Alvarez MT; Quintana M; Martin-Salces M; Hernandez-Navarro F Haemophilia; 2008 Nov; 14 Suppl 6():28-35. PubMed ID: 19134031 [TBL] [Abstract][Full Text] [Related]
13. FEIBA in the treatment of acquired haemophilia A: results from the prospective multicentre French 'FEIBA dans l'hémophilie A acquise' (FEIBHAC) registry. Borg JY; Négrier C; Durieu I; Dolimier E; Masquelier AM; Lévesque H; Haemophilia; 2015 May; 21(3):330-337. PubMed ID: 25359571 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of FEIBA for acute bleeding and surgical haemostasis in haemophilia A patients with inhibitors: a multicentre registry in Turkey. Zülfikar B; Aydogan G; Salcioglu Z; Oner AF; Kavakli K; Gursel T; Zülfikar H; Haemophilia; 2012 May; 18(3):383-91. PubMed ID: 22103429 [TBL] [Abstract][Full Text] [Related]
15. FEIBA safety profile in multiple modes of clinical and home-therapy application. Luu H; Ewenstein B Haemophilia; 2004 Sep; 10 Suppl 2():10-6. PubMed ID: 15385041 [TBL] [Abstract][Full Text] [Related]
16. [Prevention of joint damage in hemophilic children with early prophylaxis]. Kreuz W; Escuriola Ettingshausen C; Funk M; Pons S; Schmidt H; Kornhuber B Orthopade; 1999 Apr; 28(4):341-6. PubMed ID: 10335528 [TBL] [Abstract][Full Text] [Related]
17. FEIBA in treatment of acute bleeding episodes in patients with haemophilia A and factor VIII inhibitors: a retrospective survey in regional haemophilia centre. Smejkal P; Brabec P; Matyskova M; Bulikova A; Slechtova M; Kissova J; Chlupova G; Muzik J; Penka M Haemophilia; 2009 May; 15(3):743-51. PubMed ID: 19432925 [TBL] [Abstract][Full Text] [Related]
18. Randomized comparison of prophylaxis and on-demand regimens with FEIBA NF in the treatment of haemophilia A and B with inhibitors. Antunes SV; Tangada S; Stasyshyn O; Mamonov V; Phillips J; Guzman-Becerra N; Grigorian A; Ewenstein B; Wong WY Haemophilia; 2014 Jan; 20(1):65-72. PubMed ID: 23910578 [TBL] [Abstract][Full Text] [Related]
19. Concomitant infusion of low doses of rFVIIa and FEIBA in haemophilia patients with inhibitors. Martinowitz U; Livnat T; Zivelin A; Kenet G Haemophilia; 2009 Jul; 15(4):904-10. PubMed ID: 19473416 [TBL] [Abstract][Full Text] [Related]
20. When should prophylaxis therapy in inhibitor patients be considered? Young G; Auerswald G; Jimenez-Yuste V; Konkle BA; Lambert T; Morfini M; Santagostino E; Blanchette V Haemophilia; 2011 Sep; 17(5):e849-57. PubMed ID: 21418444 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]